Edwards Lifesciences Historical Valuation Analysis

Some fundamental drivers such as market cap or Edwards Lifesciences enterprice value can be analyzed from historical prospective to project value of the company into the future. Some investors analyze Edwards Lifesciences valuation indicators such as Average Assets of 4.2 B or Earnings Before Interest Taxes and Depreciation Amortization EBITDA of 1.1 B to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Edwards Lifesciences future value. Financial Statement Analysis is much more than just reviewing and breaking down Edwards Lifesciences prevalent accounting reports in order to predict its past. Macroaxis encourages investors to analyze financial statement over time for various trends across multiple indicators and accounts to determine whether Edwards Lifesciences is a good buy for the upcoming year. Additionally see Investing Opportunities.
Symbol
Analyze Trends

Edwards Lifesciences Corporation Valuation Data Chart

Net Income Per Employee    Enterprise Value    Market Capitalization    

Enterprise Value

Enterprise Value (or EV) is usually referred to as Edwards Lifesciences theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Edwards Lifesciences debt, but would also pocket its cash. Enterprise Value is more accurate representation of Edwards Lifesciences value then its market capitalization because it takes into account all of Edwards Lifesciences Corporation existing debt. Enterprise value is a measure of the value of a business as a whole, calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Edwards Lifesciences Corporation. It is equal to Edwards Lifesciences current share price times the number of Edwards Lifesciences outstanding shares. Represents the product of Total Shares (Basic) , Adjusted Share Price and Entity Share Factor.